|
|
------------------------------------------------------------------------Contents (.PDF) Federal RegisterContents (.TXT) Vol. 63, No. 212Tuesday, November 3, 1998------------------------------------------------------------------------Food and Drug Administration Some of these documents may also contain internal hyperlinks to other documents RULES New Animal Drugs for Use in Animal Feeds; Carbadox. Page 59216 [FR Doc. 98-29334] (CVM 98133 NADA 041-061) [TEXT] [PDF] FREEDOM OF INFORMATION SUMMARY Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium. Pages 59215-59216 [FR Doc. 98-29332] (CVM 984 NADA 122-578) [TEXT] [PDF] FREEDOM OF INFORMATION SUMMARY Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers. Pages 59213-59215 [FR Doc. 98-29333] (CFSAN 9889, Docket No. 96F-0214) [TEXT] [PDF] FINDING OF NO SIGNIFICANT IMPACT Environmental Assessment Medical Devices: Exemptions from Premarket Notification Class II Devices. Pages 59222-59231 [FR Doc. 98-29189] (CDRH 9827, Docket 98N-0015) [TEXT] [PDF] Medical Devices; Humanitarian Use of Devices. Pages 59217-59222 [FR Doc. 98-29391] (CDRH 9890, Docket No. 98N-0171) [TEXT] [PDF] NOTICES Agency Information Collection Activities; Announcement of OMB Approval; Amendments to Humanitarian Use Device (HUD) Requirements. Page 59315 [FR Doc. 98-29392] (OC98360, Docket No 98n-0515) [TEXT] [PDF] GUIDANCES Guidance on Criteria and Approaches for Postmarket Surveillance; Availability. Pages 59315-59316 [FR Doc. 98-29390] (CDRH 9881, Docket 98D-0672) [TEXT] [PDF] The guidance document SMDA to FDAMA: Guidance on FDA's Transition Plan for Existing Postmarket Surveillance Protocols; Availability. Pages 59316-59317 [FR Doc. 98-29389] (CDRH 9888, Docket 98D-0108) [TEXT] [PDF] The guidance document Semiannual Guidance Agenda. Pages 59317-59326 (OC 98323, Docket No. 98D-0928) [TEXT] [PDF]
|